Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 11/20 | 0.39 |
| ▸ | CNR2 | P34972 | 10/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ACAT1 | P24752 | 1/20 | 0.35 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.35 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20140282 | 1.00 | AHR (0.39) | AHRCNR1CNR2PTGS2ALDH1A1 | |
| SCHEMBL20140283 | 1.00 | AHR (0.39) | AHRCNR1CNR2PTGS2ALDH1A1 | |
| SCHEMBL23162444 | 0.94 | CNR1 (0.45) | AHRCNR1CNR2PTGS2KDM4E | |
| SCHEMBL23162443 | 0.94 | CNR1 (0.45) | AHRCNR1CNR2PTGS2KDM4E | |
| SCHEMBL23461925 | 0.89 | ALDH1A1 (0.32) | AHRCNR1CNR2ALDH1A1CYP1A1 | |
| SCHEMBL23461329 | 0.89 | CNR1 (0.36) | AHRCNR1CNR2PTGS2ALDH1A1 | |
| SCHEMBL21286872 | 0.85 | EPHX2 (0.41) | CNR1CNR2CYP3A4TSHR | |
| SCHEMBL23461625 | 0.83 | CNR1 (0.35) | CNR1CNR2ALDH1A1KDM4ETP53 | |
| SCHEMBL23461627 | 0.83 | CNR1 (0.35) | CNR1CNR2ALDH1A1KDM4ETP53 | |
| SCHEMBL23202602 | 0.83 | ALDH1A1 (0.41) | AHRCNR1CNR2PTGS2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190315669-A1 | PROCESS FOR THE PREPARATION OF HU-910 AND CRYSTALLINE STRUCTURE THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2019-10-17 | — | — | US | disclosed |
| WO-2018087767-A1 | PROCESS FOR THE PREPARATION OF HU-910 AND CRYSTALLINE STRUCTURE THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2018-05-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190315669-A1 | PROCESS FOR THE PREPARATION OF HU-910 AND CRYSTALLINE STRUCTURE THEREOF | HUWE1, SNRNP200, UACA | AHR 3382/4885CNR1 2723/4885CNR2 3253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.